Global Hyoscine-N-Butyl Bromide Market Insights, Forecast to 2025
Hyoscine-N-Butyl Bromideis obtained from a species of the plant genus Duboisia. It is mainly classified as an antispasmodic, which means that it is a drug used to suppress of muscle spasms, or involuntary contractions.
It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms.
Hyoscine-N-Butyl Bromideis obtained from a species of the plant genus Duboisia. It is mainly classified as an antispasmodic, which means that it is a drug used to suppress of muscle spasms, or involuntary contractions.
The production of Hyoscine-N-Butyl Bromideis increased from 6.3 MT in 2012 to 6.9 MT in 2016, at a CARG 2.54%. The manufacturers are Boehringer-Ingelheim, Linnea, Alchem International and Alkaloids.
Boehringer-Ingelheim is the world leader with 77.62% of market share in 2016. Boehringer-Ingelheim produces both Hyoscine-N-Butyl Bromideis API and Buscopan. They mainly sale Buscopan in market and the revenue of Buscopan is 236 EUR million and the revenue of Hyoscine-N-Butyl Bromideis API is 30.2 million USD in 2016.
Global Hyoscine-N-Butyl Bromide market size will increase to 63 Million US$ by 2025, from 40 Million US$ in 2018, at a CAGR of 5.9% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hyoscine-N-Butyl Bromide.
This report researches the worldwide Hyoscine-N-Butyl Bromide market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Hyoscine-N-Butyl Bromide breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
The following manufacturers are covered in this report:
Boehringer-Ingelheim
Linnea, Alchem International
Alkaloids
Hyoscine-N-Butyl Bromide Breakdown Data by Type
Boehringer-Ingelheim
Linnea
Alchem International
Alkaloids
Hyoscine-N-Butyl Bromide Breakdown Data by Application
Oral
Injection
Hyoscine-N-Butyl Bromide Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions
Hyoscine-N-Butyl Bromide Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives are:
To analyze and research the global Hyoscine-N-Butyl Bromide capacity, production, value, consumption, status and forecast;
To focus on the key Hyoscine-N-Butyl Bromide manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Hyoscine-N-Butyl Bromide :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms.
Hyoscine-N-Butyl Bromideis obtained from a species of the plant genus Duboisia. It is mainly classified as an antispasmodic, which means that it is a drug used to suppress of muscle spasms, or involuntary contractions.
The production of Hyoscine-N-Butyl Bromideis increased from 6.3 MT in 2012 to 6.9 MT in 2016, at a CARG 2.54%. The manufacturers are Boehringer-Ingelheim, Linnea, Alchem International and Alkaloids.
Boehringer-Ingelheim is the world leader with 77.62% of market share in 2016. Boehringer-Ingelheim produces both Hyoscine-N-Butyl Bromideis API and Buscopan. They mainly sale Buscopan in market and the revenue of Buscopan is 236 EUR million and the revenue of Hyoscine-N-Butyl Bromideis API is 30.2 million USD in 2016.
Global Hyoscine-N-Butyl Bromide market size will increase to 63 Million US$ by 2025, from 40 Million US$ in 2018, at a CAGR of 5.9% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hyoscine-N-Butyl Bromide.
This report researches the worldwide Hyoscine-N-Butyl Bromide market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Hyoscine-N-Butyl Bromide breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
The following manufacturers are covered in this report:
Boehringer-Ingelheim
Linnea, Alchem International
Alkaloids
Hyoscine-N-Butyl Bromide Breakdown Data by Type
Boehringer-Ingelheim
Linnea
Alchem International
Alkaloids
Hyoscine-N-Butyl Bromide Breakdown Data by Application
Oral
Injection
Hyoscine-N-Butyl Bromide Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions
Hyoscine-N-Butyl Bromide Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives are:
To analyze and research the global Hyoscine-N-Butyl Bromide capacity, production, value, consumption, status and forecast;
To focus on the key Hyoscine-N-Butyl Bromide manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Hyoscine-N-Butyl Bromide :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
